Caricamento...
Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells
BACKGROUND: Despite the progress made in the clinical management of metastatic melanoma, a patient’s response to treatment cannot be fully predicted, and intrinsic or acquired resistance that is developed in most melanoma patients warrants further research efforts. In addition to genetic factors, mi...
Salvato in:
| Pubblicato in: | Cancer Manag Res |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501594/ https://ncbi.nlm.nih.gov/pubmed/32982400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S263767 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|